Acceptance and Commitment Therapy-based Intervention for Loneliness Among Older Adults Living Alone
Launched by CHINESE UNIVERSITY OF HONG KONG · Dec 5, 2024
Trial Information
Current as of May 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special kind of therapy called Acceptance and Commitment Therapy (ACT) to help older adults who feel lonely. The study will focus on older adults living alone in Hong Kong and aims to see if this therapy can reduce their feelings of loneliness and improve their overall well-being. Researchers will also explore how the therapy affects participants' ability to adapt to life's challenges and how they feel about their health. Additionally, the study will gather insights from older adults about their experiences with the therapy and its impact on their loneliness.
To be eligible for this trial, participants must be at least 60 years old, live at home (not in a care facility), and have experienced loneliness for more than a year. They should be able to speak and understand Chinese and score a certain level of loneliness on a screening test. However, those who are currently receiving psychological treatment, have a diagnosed mental illness, or have significant cognitive or communication difficulties will not be able to participate. If eligible, participants can expect to join sessions focused on improving their mental health and will be asked about their feelings and experiences throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • older adults aged 60 years or above
- • residing in the community (living at home without being institutionalised in the past 6 months)
- • capable of speaking and understanding Chinese
- • experiencing loneliness (scoring ≥3 on a three-item loneliness screening scale)
- • living alone for more than 1 year
- Exclusion Criteria:
- • currently undergoing psychological intervention
- • having a clinical diagnosis of mental illness
- • being cognitively impaired (Abbreviated Mental Test score \<6)
- • having visual/language/communication difficulties
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported